NCT02666846View on ClinicalTrials.gov

Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Pain
Interventions
DRUG

Ibuprofen

DRUG

Diclofenac

DRUG

Methyl-salicylate / Menthol

DRUG

Placebo

Trial Locations (1)

HA1 3UJ

PAREXEL EPCU Northwick Park, Harrow

Sponsors

Collaborators (1)

Parexel
All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

Futura Medical Developments Ltd.

INDUSTRY

NCT02666846 - Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model | Biotech Hunter | Biotech Hunter